{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:20:32Z","timestamp":1768278032847,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-025-00738-4","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T09:38:50Z","timestamp":1743759530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sero-prevalence of cryptococcal antigen and its immune-virological correlates in HIV-1 positive individuals: a prospective cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-3631","authenticated-orcid":false,"given":"Bukhari Isah","family":"Shuaib","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Momodu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareedah","family":"Momodu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bumojo Hope","family":"Agada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"738_CR1","doi-asserted-by":"publisher","unstructured":"Eric E, Olupot-Olupot P, Bwayo D, Meya D, Katuramu R. Prevalence and factors associated with Cryptococcal antigenemia among patients with advanced human immunodeficiency virus in Eastern Uganda: A facility-based cross-sectional study. Open Forum Infect Dis. 2023;10(7). https:\/\/doi.org\/10.1093\/ofid\/ofad351.","DOI":"10.1093\/ofid\/ofad351"},{"issue":"6","key":"738_CR2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1093\/cid\/ciu937","volume":"60","author":"J McKenney","year":"2014","unstructured":"McKenney J, Bauman S, Neary B, Detels R, French A, Margolick J, et al. Prevalence, correlates, and outcomes of Cryptococcal antigen positivity among patients with AIDS, united States, 1986\u20132012. Clin Infect Dis. 2014;60(6):959\u201365. https:\/\/doi.org\/10.1093\/cid\/ciu937.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"738_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5001\/omj.2012.51","volume":"27","author":"F Osazuwa","year":"2012","unstructured":"Osazuwa F, Dirisu JO, Okuonghae PE, Ugbebor O. Screening for Cryptococcal antigenemia in anti-retroviral Na\u00efve AIDS patients in Benin City, Nigeria. Oman Med J. 2012;27(3):228\u201331. https:\/\/doi.org\/10.5001\/omj.2012.51.","journal-title":"Oman Med J"},{"key":"738_CR4","doi-asserted-by":"publisher","unstructured":"Oladele RO, Akanmu AS, Nwosu AO, Ogunsola FT, Richardson MD, Denning DW. Cryptococcal antigenemia in Nigerian patients with advanced human immunodeficiency virus: influence of antiretroviral therapy adherence. Open Forum Infect Dis. 2016;3(2). https:\/\/doi.org\/10.1093\/ofid\/ofw055.","DOI":"10.1093\/ofid\/ofw055"},{"issue":"1","key":"738_CR5","doi-asserted-by":"publisher","first-page":"e0001313","DOI":"10.1371\/journal.pgph.0001313","volume":"3","author":"RO Oladele","year":"2023","unstructured":"Oladele RO, Jordan AM, Okaa JU, Osaigbovo II, Shettima SA, Shehu NY, et al. A multicenter survey of asymptomatic Cryptococcal antigenemia among patients with advanced HIV disease in Nigeria. PLOS Glob Public Health. 2023;3(1):e0001313. https:\/\/doi.org\/10.1371\/journal.pgph.0001313.","journal-title":"PLOS Glob Public Health"},{"issue":"4","key":"738_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/cid\/ciac675","volume":"76","author":"RM Wake","year":"2022","unstructured":"Wake RM, Molloy SF, Jarvis JN, Harrison TS, Govender NP. Cryptococcal antigenemia in advanced human immunodeficiency virus disease: pathophysiology, epidemiology, and clinical implications. Clin Infect Dis. 2022;76(4):764\u201370. https:\/\/doi.org\/10.1093\/cid\/ciac675.","journal-title":"Clin Infect Dis"},{"issue":"suppl2","key":"738_CR7","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1093\/cid\/cix1139","volume":"66","author":"N Ford","year":"2018","unstructured":"Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, et al. Managing advanced HIV disease in a public health approach. Clin Infect Dis. 2018;66(suppl2):S106\u201310. https:\/\/doi.org\/10.1093\/cid\/cix1139.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"738_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s11904-010-0061-5","volume":"7","author":"EH Geng","year":"2010","unstructured":"Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, et al. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV\/AIDS Rep. 2010;7(4):234\u201344. https:\/\/doi.org\/10.1007\/s11904-010-0061-5.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"738_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"AB Kharsany","year":"2016","unstructured":"Kharsany AB, Karim QA. HIV infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34\u201348. https:\/\/doi.org\/10.2174\/1874613601610010034.","journal-title":"Open AIDS J"},{"issue":"2","key":"738_CR10","doi-asserted-by":"publisher","first-page":"ofac004","DOI":"10.1093\/ofid\/ofac004","volume":"9","author":"M Okwir","year":"2022","unstructured":"Okwir M, Link A, Rhein J, Obbo JS, Okello J, Nabongo B, et al. High burden of Cryptococcal meningitis among antiretroviral therapy-experienced HIV-infected patients in Northern Uganda in the era of test and treat: implications for Cryptococcal screening programs. Open Forum Infect Dis. 2022;9(2):ofac004. https:\/\/doi.org\/10.1093\/ofid\/ofac004.","journal-title":"Open Forum Infect Dis"},{"key":"738_CR11","doi-asserted-by":"crossref","first-page":"e020622205560","DOI":"10.2174\/1573404819666220602110733","volume":"20","author":"O Balogun","year":"2022","unstructured":"Balogun O, Shuaib BI, Usman UA, Yusuf AA. Impact of viral load suppression on CD4\u2009+\u2009T-cell count and BMI following combine antiretroviral therapy (cART) in HIV-1 infected individuals: preliminary findings in a resource poor setting. Anti-Infective Agents. 2022;20:e020622205560.","journal-title":"Anti-Infective Agents"},{"issue":"4","key":"738_CR12","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3947\/ic.2023.0080","volume":"55","author":"A Usman","year":"2023","unstructured":"Usman A, Balogun O, Shuaib BI, Musa BOP, Yusuf AA, Ajayi EIO. Prevalence of cytopenia and its correlation with immunosuppression in Na\u00efve HIV-1 infected patients initiating first-line antiretroviral therapy: a pilot study. Infect Chemother. 2023;55(4):479\u201389. https:\/\/doi.org\/10.3947\/ic.2023.0080.","journal-title":"Infect Chemother"},{"issue":"9534","key":"738_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0140-6736(06)69157-5","volume":"368","author":"V Simon","year":"2006","unstructured":"Simon V, Ho DD, Karim QA. HIV\/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368(9534):489\u2013504. https:\/\/doi.org\/10.1016\/S0140-6736(06)69157-5.","journal-title":"Lancet"},{"key":"738_CR14","unstructured":"UNAIDS. (2021). Confronting Inequalities: Lessons for pandemic responses from 40 years of AIDS. https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021-global-aids-update"},{"key":"738_CR15","unstructured":"UNAIDS. (2020). Global HIV & AIDS statistics \u2014 2020 fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"issue":"10","key":"738_CR16","doi-asserted-by":"publisher","first-page":"e1002656","DOI":"10.1371\/journal.pmed.1002656","volume":"15","author":"N Ford","year":"2018","unstructured":"Ford N, Migliori GB, Marks G, Raviglione M, Armstrong LR, Centis R, Horsburgh CR. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Med. 2018;15(10):e1002656. https:\/\/doi.org\/10.1371\/journal.pmed.1002656.","journal-title":"PLoS Med"},{"key":"738_CR17","volume-title":"Guidelines for diagnosing, preventing and managing Cryptococcal disease among adults, adolescents and children living with HIV","author":"World Health Organization (WHO)","year":"2022","unstructured":"World Health Organization (WHO). Guidelines for diagnosing, preventing and managing Cryptococcal disease among adults, adolescents and children living with HIV. Geneva: World Health Organization; 2022. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK581832\/."},{"issue":"4","key":"738_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s11904-010-0061-5","volume":"7","author":"EH Geng","year":"2010","unstructured":"Geng EH, Nash D, Kambugu A, Zhang Y, Braitstein P, Christopoulos KA, Martin JN. Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV\/AIDS Rep. 2010;7(4):234\u201344. https:\/\/doi.org\/10.1007\/s11904-010-0061-5.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"12","key":"738_CR19","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3390\/jof8121284","volume":"8","author":"EV Mimicos","year":"2022","unstructured":"Mimicos EV, Fossaluza V, De Melo Picone C, De Sena CC, Gomes HR, L\u00e1zari CDS, et al. Prevalence and associated factors of Cryptococcal antigenemia in HIV-infected patients with CD4\u2009<\u2009200 cells\/\u00b5l in S\u00e3o Paulo, Brazil: A bayesian analysis. J Fungi. 2022;8(12):1284. https:\/\/doi.org\/10.3390\/jof8121284.","journal-title":"J Fungi"},{"issue":"2","key":"738_CR20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4314\/ahs.v12i2.8","volume":"12","author":"JP Dzoyem","year":"2012","unstructured":"Dzoyem JP, Kechia FA, Ngaba GP, Lunga PK, Lohoue PJ. Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon. Afr Health Sci. 2012;12(2):129\u201333.","journal-title":"Afr Health Sci"},{"issue":"10","key":"738_CR21","doi-asserted-by":"crossref","first-page":"e75585","DOI":"10.1371\/journal.pone.0075585","volume":"8","author":"T Beyene","year":"2013","unstructured":"Beyene T, Woldeamanuel Y, Asrat D, Ayana G, Boulware DR. Comparison of Cryptococcal antigenemia between antiretroviral Naive and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia. PLoS ONE. 2013;8(10):e75585.","journal-title":"PLoS ONE"},{"key":"738_CR22","first-page":"61","volume":"6","author":"AO Abubakar","year":"2014","unstructured":"Abubakar AO, Maikai BV, Musa BO, Olayinka AT. Public health implications of Cryptococcal infection among HIV patients on antiretroviral therapy in hospital in Shika, Nigeria. Online J Public Health Inf. 2014;6:61\u20133.","journal-title":"Online J Public Health Inf"},{"issue":"7","key":"738_CR23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.9734\/BJMMR\/2015\/14576","volume":"6","author":"G Joseph","year":"2015","unstructured":"Joseph G, Ogbaini\u2013Emovon E, Okwara BU, Onunu A, Kubeyinje E. Prevalence of disseminated cryptococcosis among human immunodeficiency virus infected patients in Benin City, Nigeria. Br J Med Med Res. 2015;6(7):715\u201322.","journal-title":"Br J Med Med Res"},{"issue":"5","key":"738_CR24","first-page":"344","volume":"50","author":"OF Osazuwa","year":"2012","unstructured":"Osazuwa OF, Dirisu O, Okunghae E. Cryptococcal antigenemia in anti\u2013retroviral Na\u00efve AIDS patients: prevalence and its association with CD4 cell count. Acta Med Iran. 2012;50(5):344\u20137.","journal-title":"Acta Med Iran"},{"key":"738_CR25","first-page":"2","volume":"1","author":"OM Ogba","year":"2015","unstructured":"Ogba OM, Abia-Bassey L. Cryptococcal antigenemia among HIV seropositive patients accessing care in antiretroviral therapy (ART) clinics in Calabar, South Southern Nigeria. J Microbiol Infect. 2015;1:2.","journal-title":"J Microbiol Infect"},{"issue":"4","key":"738_CR26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4314\/njm.v19i4.61963","volume":"19","author":"SS Gomerep","year":"2010","unstructured":"Gomerep SS, Idoko JA, Ladep NG, Ugoya SO, Obaseki D, Agbaji OA, et al. Frequency of Cryptococcal meningitis in HIV1 infected patients in North central Nigeria. Niger J Med. 2010;19(4):395\u20139.","journal-title":"Niger J Med"},{"issue":"1","key":"738_CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-3156.2010.02683.x","volume":"16","author":"Y Mamoojee","year":"2011","unstructured":"Mamoojee Y, Shakoor S, Gorton RL, Sarfo S, Appiah LT, Norman B, et al. Low Seroprevalence of Cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana. Trop Med Int Health. 2011;16(1):53\u20136.","journal-title":"Trop Med Int Health"},{"issue":"18","key":"738_CR28","first-page":"15","volume":"l3","author":"R Chukwuanukwu","year":"2013","unstructured":"Chukwuanukwu R, Manafa P, Iloghalu E, Onyenekwe C, Ifeanyichukwu M, Mbamalu C. Cryptococcus neoformans antigenemia in HIV positive pregnant women attending PMTCT clinic in South Eastern Nigeria. J Biol Agric Healthc. 2013;l3(18):15\u201321.","journal-title":"J Biol Agric Healthc"},{"issue":"2","key":"738_CR29","doi-asserted-by":"publisher","first-page":"e0294940","DOI":"10.1371\/journal.pone.0294940","volume":"19","author":"M Minja","year":"2024","unstructured":"Minja M, Mbilinyi T, Mkinga B, Philipo EG, Owenya J, Kilonzi M. Prevalence, treatment, and factors associated with Cryptococcal meningitis post introduction of integrase inhibitors antiretroviral-based regimens among people living with HIV in Tanzania. PLoS ONE. 2024;19(2):e0294940. https:\/\/doi.org\/10.1371\/journal.pone.0294940.","journal-title":"PLoS ONE"},{"issue":"11\u201312","key":"738_CR30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s11046-016-0048-x","volume":"181","author":"AF Henao-Mart\u00ednez","year":"2016","unstructured":"Henao-Mart\u00ednez AF, Gross L, Mcnair B, McCollister B, DeSanto K, Montoya JG, Shapiro L, Beckham JD. Risk factors for Cryptococcal meningitis: a single united States center experience. Mycopathologia. 2016;181(11\u201312):807\u201314. https:\/\/doi.org\/10.1007\/s11046-016-0048-x.","journal-title":"Mycopathologia"},{"key":"738_CR31","unstructured":"World Health Organization. (2020). Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Health Organization. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/332294"},{"key":"738_CR32","unstructured":"Sadiq U, Shrestha U, Guzman N. Prevention of opportunistic infections in HIV\/AIDS. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK513345"},{"issue":"10","key":"738_CR33","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1258\/ijsa.2010.010182","volume":"21","author":"T Warkentien","year":"2010","unstructured":"Warkentien T, Crum-Cianflone NF. An update on Cryptococcus among HIV-infected patients. Int J STD AIDS. 2010;21(10):679\u201384. https:\/\/doi.org\/10.1258\/ijsa.2010.010182.","journal-title":"Int J STD AIDS"},{"issue":"4","key":"738_CR34","doi-asserted-by":"publisher","first-page":"e0015622","DOI":"10.1128\/cmr.00156-22","volume":"36","author":"TC McHale","year":"2023","unstructured":"McHale TC, Boulware DR, Kasibante J, Ssebambulidde K, Skipper CP, Abassi M. Diagnosis and management of Cryptococcal meningitis in HIV-infected adults. Clin Microbiol Rev. 2023;36(4):e0015622. https:\/\/doi.org\/10.1128\/cmr.00156-22.","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"738_CR35","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/pathogens12101226","volume":"12","author":"H Kirkoyun Uysal","year":"2023","unstructured":"Kirkoyun Uysal H, Koksal MO, Sarsar K, Soguksu P, Erkose Genc G, Yapar G, Ozdemir E, Onel M, Mese S, Demirci M, Erturan Z, Yurtseven E, Eraksoy OH, Agacfidan A. Distribution of opportunistic pathogens in people living with HIV at a university hospital in Istanbul over a one-year treatment period and its association with CD4 T cell counts. Pathogens. 2023;12(10):1226. https:\/\/doi.org\/10.3390\/pathogens12101226.","journal-title":"Pathogens"},{"issue":"1","key":"738_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07090-5","volume":"22","author":"M Okwir","year":"2022","unstructured":"Okwir M, Nuwasiima A, Ojok F, Andia-Biraro I, Okiria JC, Namuwenge M, Kaggwa MM. Tuberculosis and HIV co-infection among patients receiving treatment at a regional referral hospital in rural Uganda. BMC Infect Dis. 2022;22(1):1\u20138. https:\/\/doi.org\/10.1186\/s12879-022-07090-5.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"738_CR37","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1600693","volume":"375","author":"MS Cohen","year":"2016","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1600693.","journal-title":"N Engl J Med"},{"issue":"9","key":"738_CR38","doi-asserted-by":"publisher","first-page":"e25585","DOI":"10.1002\/jia2.25585","volume":"23","author":"R Handoko","year":"2020","unstructured":"Handoko R, Colby DJ, Kroon E, Sacdalan C, de Souza M, Pinyakorn S, Prueksakaew P, et al. Determinants of suboptimal CD4\u2009+\u2009T cell recovery after antiretroviral therapy initiation in a prospective cohort of acute HIV-1 infection. J Int AIDS Soc. 2020;23(9):e25585. https:\/\/doi.org\/10.1002\/jia2.25585.","journal-title":"J Int AIDS Soc"},{"issue":"16","key":"738_CR39","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","volume":"365","author":"DV Havlir","year":"2011","unstructured":"Havlir DV, Kendall MA, Ive P, Kumwenda J, Swindells S, Qasba SS, Luetkemeyer AF, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365(16):1482\u201391. https:\/\/doi.org\/10.1056\/NEJMoa1013607.","journal-title":"N Engl J Med"},{"issue":"4","key":"738_CR40","doi-asserted-by":"publisher","first-page":"716","DOI":"10.3390\/jcm10040716","volume":"10","author":"J Portilla-Tamarit","year":"2021","unstructured":"Portilla-Tamarit J, Reus S, Portilla I, Fuster Ruiz-de-Apodaca MJ, Portilla J. Impact of advanced HIV disease on quality of life and mortality in the era of combined antiretroviral treatment. J Clin Med. 2021;10(4):716. https:\/\/doi.org\/10.3390\/jcm10040716.","journal-title":"J Clin Med"},{"issue":"5","key":"738_CR41","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/COH.0000000000000298","volume":"11","author":"G Wandeler","year":"2016","unstructured":"Wandeler G, Johnson LF, Egger M. Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the Globe: comparisons with general population. Curr Opin HIV AIDS. 2016;11(5):492\u2013500. https:\/\/doi.org\/10.1097\/COH.0000000000000298.","journal-title":"Curr Opin HIV AIDS"},{"issue":"12","key":"738_CR42","doi-asserted-by":"publisher","first-page":"e1000384","DOI":"10.1371\/journal.pmed.1000384","volume":"7","author":"DR Boulware","year":"2010","unstructured":"Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, Musubire A, Lee SJ, Kambugu A, Janoff EN, Bohjanen PR. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after Cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7(12):e1000384. https:\/\/doi.org\/10.1371\/journal.pmed.1000384.","journal-title":"PLoS Med"},{"issue":"7","key":"738_CR43","doi-asserted-by":"publisher","first-page":"e020654","DOI":"10.1136\/bmjopen-2017-020654","volume":"8","author":"TK Nyazika","year":"2018","unstructured":"Nyazika TK, Tatuene JK, Kenfak-Foguena A, Verweij PE, Meis JF, Robertson VJ, Hagen F. Epidemiology and aetiologies of Cryptococcal meningitis in Africa, 1950\u20132017: protocol for a systematic review. BMJ Open. 2018;8(7):e020654. https:\/\/doi.org\/10.1136\/bmjopen-2017-020654.","journal-title":"BMJ Open"},{"issue":"6","key":"738_CR44","doi-asserted-by":"publisher","first-page":"myae043","DOI":"10.1093\/mmy\/myae043","volume":"62","author":"A Dao","year":"2024","unstructured":"Dao A, Kim HY, Garnham K, Kidd S, Sati H, Perfect J, Sorrell TC, et al. Cryptococcosis\u2014a systematic review to inform the world health organization fungal priority pathogens list. Med Mycol. 2024;62(6):myae043. https:\/\/doi.org\/10.1093\/mmy\/myae043.","journal-title":"Med Mycol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00738-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T01:26:03Z","timestamp":1743816363000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00738-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["738"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00738-4","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the hospital research ethics committee of Edo State University, Uzarue, Nigeria (ethical approval number: EDSUREC23\/0074). Informed consent was obtained from all the participants in accordance with Helsinki Declaration of 1975, as revised in 2000; voluntariness and strict confidentiality were maintained throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"41"}}